| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |